ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,616Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 26

$375K Total Retail Price of All Prescriptions

Rank: 8 out of 26

213 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 213 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,437 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 355 355 1 3
FUROSEMIDE 333 333 2 5
LISINOPRIL 276 261 3 2
METOPROLOL TARTRATE 275 275 4 4
AMLODIPINE BESYLATE 247 247 5 1
OMEPRAZOLE 236 230 6 8
SERTRALINE HCL 226 226 7 15
MIRTAZAPINE 211 211 8 9
WARFARIN SODIUM 204 204 9 7
DONEPEZIL HCL 203 203 10 11
PRAVASTATIN SODIUM 179 179 11 17
METOPROLOL SUCCINATE 143 143 12 22
CITALOPRAM HBR 136 124 13 10
TRAMADOL HCL 120 120 14 13
QUETIAPINE FUMARATE 115 115 15 27
ESCITALOPRAM OXALATE 111 111 16 47
PANTOPRAZOLE SODIUM 111 111 16 23
TRIAMCINOLONE ACETONIDE 105 105 18 85
CLOPIDOGREL 102 102 19 36
METFORMIN HCL 100 100 20 18
TRAZODONE HCL 97 97 21 14
LIDODERM 95 95 22 54
FAMOTIDINE 94 94 23 60
GABAPENTIN 93 93 24 12
TAMSULOSIN HCL 91 91 25 35
SIMVASTATIN 88 88 26 6
CIPROFLOXACIN HCL 86 86 27 66
SEROQUEL 85 85 28 48
POLYETHYLENE GLYCOL 3350 83 83 29 24
DIGOXIN 83 83 29 50
LEVETIRACETAM 80 68 31 29
CYMBALTA 76 76 32 45
POTASSIUM CHLORIDE 74 53 33 31
PLAVIX 68 68 34 44
NAMENDA 66 66 35 25
KLOR-CON M20 65 65 36 49
DILTIAZEM 24HR ER 64 64 37 104
PREDNISONE 59 59 38 40
LOSARTAN POTASSIUM 57 57 39 39
HYDROCHLOROTHIAZIDE 56 56 40 20
LEVOFLOXACIN 56 56 40 58
CARBIDOPA-LEVODOPA 54 54 42 59
ATENOLOL 54 54 42 26
RISPERIDONE 51 51 44 19
ZOLPIDEM TARTRATE 51 51 44 37
RANITIDINE HCL 51 43 44 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.